Identity
HGNC
LOCATION
10q23.1
LOCUSID
ALIAS
HRG3,pro-NRG3
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 10718
MIM: 605533
HGNC: 7999
Ensembl: ENSG00000185737
Variants:
dbSNP: 10718
ClinVar: 10718
TCGA: ENSG00000185737
COSMIC: NRG3
RNA/Proteins
Expression (GTEx)
Pathways
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA10040 | cetuximab | Chemical | Pathway | associated | |||
| PA161199368 | iloperidone | Chemical | ClinicalAnnotation | associated | PD | 18521091 | |
| PA162373091 | panitumumab | Chemical | Pathway | associated | |||
| PA447300 | Acquired Long QT Syndrome (aLQTS) | Disease | ClinicalAnnotation | associated | PD | 18521091 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 35579602 | 2022 | Transcytosis and trans-synaptic retention by postsynaptic ErbB4 underlie axonal accumulation of NRG3. | 3 |
| 35579602 | 2022 | Transcytosis and trans-synaptic retention by postsynaptic ErbB4 underlie axonal accumulation of NRG3. | 3 |
| 34247340 | 2021 | Association of NRG3 and ERBB4 gene polymorphism with nicotine dependence in Turkish population. | 1 |
| 34247340 | 2021 | Association of NRG3 and ERBB4 gene polymorphism with nicotine dependence in Turkish population. | 1 |
| 31753594 | 2020 | NRG3 contributes to cognitive deficits in chronic patients with schizophrenia. | 14 |
| 32066712 | 2020 | Neuregulin 3 rs10748842 polymorphism contributes to the effect of body mass index on cognitive impairment in patients with schizophrenia. | 11 |
| 31753594 | 2020 | NRG3 contributes to cognitive deficits in chronic patients with schizophrenia. | 14 |
| 32066712 | 2020 | Neuregulin 3 rs10748842 polymorphism contributes to the effect of body mass index on cognitive impairment in patients with schizophrenia. | 11 |
| 30287910 | 2019 | Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort. | 5 |
| 30287910 | 2019 | Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort. | 5 |
| 27771971 | 2017 | Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders. | 18 |
| 28256518 | 2017 | Effects of RET, NRG1 and NRG3 Polymorphisms in a Chinese Population with Hirschsprung Disease. | 17 |
| 27771971 | 2017 | Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders. | 18 |
| 28256518 | 2017 | Effects of RET, NRG1 and NRG3 Polymorphisms in a Chinese Population with Hirschsprung Disease. | 17 |
| 27449290 | 2016 | KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway. | 7 |
Citation
Dessen P
NRG3 (neuregulin 3)
Atlas Genet Cytogenet Oncol Haematol. 2003-05-01
Online version: http://atlasgeneticsoncology.org/gene/41580/nrg3
